The DOI matches its Crossref record.
Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the improvements in ppFEV 1 by genotype observed in this study were broadly consistent with what has been reported in ELX/TEZ/IVA Phase 3 clinical trials (14.3, 10.0, and 3.7 percentage points in people with an F /MF genotype, F/F genotype, and F /G and F /RF genotypes, respectively) [ 8 , 9 , 17 ].”
From Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 8
- 10.1183/09031936.00166412 · DOI · Paper page
- 10.1056/NEJMoa2100665 · DOI
- 10.1056/NEJMoa1409547 · DOI · Paper page
- 10.1056/NEJMe1712335 · DOI
- 10.1136/bmjopen-2020-040806 · DOI
- 10.1016/j.jcf.2018.02.006 · DOI · Paper page
- 10.1016/S2213-2600(16)30427-1 · DOI · Paper page
- 10.1016/j.jcf.2015.01.005 · DOI
Cited by
Sorted by citations
Bower, J. K., Volkova, N., Ahluwalia, N., Sahota, G., Xuan, F., Chin, A., Weinstock, T. G., Ostrenga, J., & Elbert, A. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.03.002 · Cited by 140
Metadata
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-12-02
- Volume
- 385
- Issue
- 23
- Pages
- 2207-2208
- ISSN
- 0028-4793
- 1533-4406
- Cited by
- 3
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes. https://app.cochat.ai/papers/10.1056/nejmc2115966
- The paper
- Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes. (2021). New England Journal of Medicine. https://doi.org/10.1056/nejmc2115966
